Use of a sensitive receptor binding assay to discriminate between full-length and truncated human recombinant tumor necrosis factor proteins.
Open Access
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 262 (3) , 958-961
- https://doi.org/10.1016/s0021-9258(19)75733-0
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferonNature, 1985
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- CACHECTIN/TUMOUR-NECROSIS-FACTOR PRODUCTION BY CANCER PATIENTSThe Lancet, 1985
- High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.The Journal of Experimental Medicine, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Molecular Cloning of the Complementary DNA for Human Tumor Necrosis FactorScience, 1985
- Cloning and expression in Escherichia coli of the gene for human tumour necrosis factorNature, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984
- Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1)Journal of Immunological Methods, 1981